Tsukasa Baba

36PUBLICATIONS
138CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 26, 2026
Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

|May 13, 2026
Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

|Apr 24, 2026
Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology.

|Mar 12, 2026
A Novel CDK12 Inhibitor Induces Homologous Recombination Deficiency to Enhance PARP Inhibitor Efficacy in Uterine Serous Carcinoma.

Shunsuke Kawahara, Mana Taki, Junzo Hamanishi

|Feb 13, 2026
Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Hemian Zhang, Masayuki Futagami, Rie Miura

|Jan 22, 2026
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.

Sho Sato, Masahiro Kagabu, Ami Jo

Pageof 6

Frequent Collaborators

10 joint publications

Tadahiro Shoji

9 joint publications

Satoru Nagase

8 joint publications

Ken Yamaguchi

8 joint publications

Hideki Tokunaga